切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 5 -9. doi: 10.3877/cma.j.issn.2095-3259.2015.01.002

所属专题: 文献

专家论坛

妊娠合并白血病
张晓红1,(), 王大鹏1   
  1. 1. 100044 北京大学人民医院妇产科
  • 收稿日期:2014-09-11 出版日期:2015-02-18
  • 通信作者: 张晓红

Leukemia in pregnancy

Xiaohong Zhang1(), Dapeng Wang1   

  • Received:2014-09-11 Published:2015-02-18
  • Corresponding author: Xiaohong Zhang
引用本文:

张晓红, 王大鹏. 妊娠合并白血病[J]. 中华产科急救电子杂志, 2015, 04(01): 5-9.

Xiaohong Zhang, Dapeng Wang. Leukemia in pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2015, 04(01): 5-9.

妊娠合并白血病是一个极其严重的产科合并症,母胎均面临高度风险。孕期应警惕患者血常规化验的异常结果,以及早诊断。孕期诊断的白血病患者需由产科、血液科综合管理,争取更好的母胎结局。本文就妊娠合并白血病的诊断、对母胎的影响、孕期的处理以及治疗过程中的伦理等问题进行讨论。

Leukemia in pregnancy is a severe obstetric complication, threatening the life of the mother and the baby. Abnormal indexes of blood test during prenatal care should be noticed to diagnose leukemia as soon as possible. The pregnant patients with leukemia should be treated under the obstetrician and hematologist to expect better maternal and fetal outcomes. In this article, the authors discussed the diagnosis, impact on mothers and fetus, obstetric management and the ethic issue of leukemia in pregnancy.

[1]
Hurley TJ. McKinnell JV, Irani MS. Hematologic malignancies in pregnancy[J]. Obstet Gynecol Clin North Am, 2005, 32(4):595-614.
[2]
Lavi N, Horowitz NA, Brenner B. An update on the management of hematologic malignancies in pregnancy[J]. Womens Health (Lond Engl), 2014, 10(3):255-266.
[3]
Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregancies at 16 years[J]. Leuk Res, 2003, 27(5):381-385
[4]
王大鹏,梁梅英,张晓红,等. 妊娠合并白血病23例临床分析[J]. 中华围产医学杂志,2014, 17(2):93-98.
[5]
Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet[J]. Blood, 2010, 115(3):453-474.
[6]
葛均波,徐永健. 内科学[M]. 8版. 北京:人民卫生出版社,2013:578.
[7]
Ali R, Ozkalemkas F, Ozkocaman V, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia(CML), and management of CML with leukapheresis during pregnancy:a case report and review of the literature[J]. Jpn J Clin Oneol, 2004, 34(4):215-217.
[8]
Saleh AJ, Alhejazi A, Ahmed SO, et al. Leukemia during pregnancy: long term follow up of 32 cases from a single institution[J]. Hematol Oncol Stem Cell Ther, 2014, 7(2):63-68.
[9]
Avivi I, Brenner B. Management of acute myeloid leukemia during pregnancy[J]. Future Oncol, 2014, 10(8):1407-1415.
[10]
Nomura RM, Igai AM, Faciroli NC, et al. Maternal and perinatal outcomes in pregnant women with leukemia[J]. Rev Bras Ginecol Obstet, 2011, 33(8):174-181.
[11]
Milojkovic D, Apperley JF. How I treat leukemia during pregnancy[J]. Blood, 2014, 123(7):974-984.
[12]
Chang A, Patel S. Treatment of acute myeloid leukemia during pregnancy[J]. Ann Pharmacother, 2015, 49(1):48-68.
[13]
Sanz MA, Jarque I, Martin G, et al. Acute promyelocytic leukemia. Therapy results and prognostic factors[J]. Cancer, 1988, 61(1):7-13.
[14]
Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy:a report on 37 patients and a review of the literature[J]. Cancer, 2005, 104(1):110-117.
[15]
Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy[J]. Blood Rev, 2008, 22(5):247-259.
[16]
王大鹏,梁梅英,张晓红,等. 妊娠合并慢性粒细胞性白血病患者的临床处理特点及妊娠结局分析[J]. 中华妇产科杂志,2010, 45(10):735-739.
[17]
Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al. A systematic review of the fetal safety of interferon alpha[J]. Reprod Toxicol, 2012, 33(3):265-268.
[18]
Webb MJ, Jafta D. Imatinib use in pregnancy[J]. Turk J Hematol, 2012, 29(4):405-408.
[19]
Yadav U, Solanki SL, Yadav R. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery[J]. J Cancer Res Ther, 2013, 9(3):484-486.
[20]
Mukhopadhyay A, Dasgupta S, Kanti Ray U, et al. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy[J]. Ir J Med Sci, 2015, 184(1):183-188.
[21]
Azim HA Jr, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors[J]. Cancer Treat Rev, 2010, 36(2):110-121.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[3] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[4] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[5] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[8] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[9] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[10] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[11] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[12] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[13] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[14] 王磊, 李梦, 孙文利, 刘瑞, 王红春, 卢光泽, 赵颖, 郭进艳, 刘红星. 液相色谱质谱法对急性白血病患者血浆代谢组学的特征分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 850-857.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要